HLA-C and variant Creutzfeldt-Jakob disease: This raised the suggestion that certain MHC class II molecules may have a direct role in vCJD pathogenesis, or alternatively, that MHC class II type HLA-DQ7 may be more effective at initiating a protective immune response following vCJD infection.